CAGLAYAN, V.; ONEN, E.; AVCI, S.; SAMBEL, M.; KILIC, M.; ONER, S.; AYDOS, M. M.; YILDIZ, H. E. Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl. Archivio Italiano di Urologia e Andrologia, [S. l.], v. 90, n. 4, p. 270–275, 2019. DOI: 10.4081/aiua.2018.4.270. Disponível em: https://www.pagepressjournals.org/aiua/article/view/aiua.2018.4.270. Acesso em: 24 nov. 2024.